{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:52:13Z","timestamp":1786737133210,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijp.ijp_364_19","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T07:20:21Z","timestamp":1607152821000},"page":"356","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of 7 days versus 10 days triple therapy based on levofloxacin-dexlansoprazole for eradication of Helicobacter pylori: A pilot randomized trial"],"prefix":"10.4103","volume":"52","author":[{"given":"AmanyMahmoud","family":"Elokaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NohaMahmoud","family":"Elkhodary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KhaledAbdalkader","family":"Farrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GamalAbd","family":"El-Hay Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.302500-1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5694\/mja16.00104","article-title":"Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection","author":"Mitchell","year":"2016","journal-title":"Med J Aust"},{"key":"key-10.4103\/0253-7613.302500-2","first-page":"886","article-title":"Does Helicobacter pylori infection play a role in iron deficiency anemia.A meta-analysis?","author":"Qu","year":"2010","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0253-7613.302500-3","first-page":"178","article-title":"H.pylori associated with iron deficiency anemia even in celiac disease patients; strongly evidence based but weakly reflected in practice","author":"Rostami-Nejad","year":"2015","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"key-10.4103\/0253-7613.302500-4","first-page":"1","article-title":"An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia","author":"Hudak","year":"2017","journal-title":"Helicobacter"},{"key":"key-10.4103\/0253-7613.302500-5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-230X-13-104","article-title":"Prevalence and risk factors of Helicobacter pylori infection in Korea: Nationwide multicenter study over 13 years","author":"Lim","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"key-10.4103\/0253-7613.302500-6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12165","article-title":"Epidemiology of Helicobacter pylori infection","author":"Eusebi","year":"2014","journal-title":"Helicobacter"},{"key":"key-10.4103\/0253-7613.302500-7","doi-asserted-by":"crossref","first-page":"17618","DOI":"10.3748\/wjg.v20.i46.17618","article-title":"Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean Region: A systematic review of prevalence and risk factors","author":"Eshraghian","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0253-7613.302500-8","doi-asserted-by":"crossref","first-page":"e12410","DOI":"10.1111\/hel.12410","article-title":"Treatment of Helicobacter pylori infection 2017","author":"O\u2019Connor","year":"2017","journal-title":"Helicobacter"},{"key":"key-10.4103\/0253-7613.302500-9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12879-018-3099-4","article-title":"The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics: Systematic review and meta-analysis","author":"Jaka","year":"2018","journal-title":"BMC Infect Dis"},{"key":"key-10.4103\/0253-7613.302500-10","first-page":"671","article-title":"Treatment of Helicobacter pylori infection in the aspect of increasing antibiotic resistance","author":"Iwa\u0144czak","year":"2012","journal-title":"Adv Clin Exp Med"},{"key":"key-10.4103\/0253-7613.302500-11","first-page":"1654907","article-title":"Efficacy and safety of the triple therapy containing ilaprazole, levofloxacin, and amoxicillin as first-line treatment in Helicobacter pylori infections","author":"Ahn","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"key-10.4103\/0253-7613.302500-12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG clinical guideline: Treatment of Helicobacter pylori infection","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/0253-7613.302500-13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/apt.13495","article-title":"Systematic review with meta-analysis: 10-or 14-day sequential therapy vs.14-day triple therapy in the first line treatment of Helicobacter pylori infection","author":"Liou","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/0253-7613.302500-14","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.3748\/wjg.v20.i18.5283","article-title":"Treatment of Helicobacter pylori infection: Current status and future concepts","author":"Yang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/0253-7613.302500-15","doi-asserted-by":"crossref","first-page":"e2698","DOI":"10.1097\/MD.0000000000002698","article-title":"A pilot randomized controlled study of dexlansoprazole MR-based triple therapy for Helicobacter pylori infection","author":"Wu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/0253-7613.302500-16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2036.2009.03933.x","article-title":"Clinical trials: Healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation Results from two randomized controlled studies","author":"Sharma","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/0253-7613.302500-17","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1365-2036.2009.03984.x","article-title":"Review article: Dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy","author":"Metz","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/0253-7613.302500-18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","article-title":"Pharmacokinetics and pharmacodynamics of the proton pump inhibitors","author":"Shin","year":"2013","journal-title":"J Neurogastroenterol Motil"},{"key":"key-10.4103\/0253-7613.302500-19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5056\/jnm15150","article-title":"Pharmacological and safety profile of dexlansoprazole: A new proton pump inhibitor \u2013 Implications for treatment of gastroesophageal reflux disease in the Asia Pacific Region","author":"Goh","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"key-10.4103\/0253-7613.302500-20","first-page":"1","article-title":"The role of acid inhibition in Helicobacter pylori eradication","author":"Scott","year":"1000","journal-title":"F"},{"key":"key-10.4103\/0253-7613.302500-21","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1590\/s1678-9946201961007","article-title":"Increased serum gastrin in patients with different clinical forms of Chagas disease coinfected with Helicobacter pylori","author":"Sousa","year":"2019","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"key-10.4103\/0253-7613.302500-22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/hel.12053","article-title":"Comparison of the diagnostic accuracy of five different stool antigen tests for the diagnosis of Helicobacter pylori infection","author":"Korkmaz","year":"2013","journal-title":"Helicobacter"},{"key":"key-10.4103\/0253-7613.302500-23","first-page":"267","article-title":"Comparison of levofloxacin versus clarithromycin efficacy in the eradication of Helicobacter pylori infection","author":"Haji-Aghamohammadi","year":"2016","journal-title":"Caspian J Intern Med"},{"key":"key-10.4103\/0253-7613.302500-24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12876-016-0491-7","article-title":"Pharmacological regimens for eradication of Helicobacter pylori: An overview of systematic reviews and network meta-analysis","author":"Xin","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"key-10.4103\/0253-7613.302500-25","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1177\/2050640618800628","article-title":"Prevalence of Helicobacter pylori infection in sexual partners of H.pylori-infected subjects: Role of gastroesophageal reflux","author":"Sgambato","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"key-10.4103\/0253-7613.302500-26","doi-asserted-by":"crossref","first-page":"e12635","DOI":"10.1111\/hel.12635","article-title":"Epidemiology of Helicobacter pylori infection","author":"Leja","year":"2019","journal-title":"Helicobacter"},{"key":"key-10.4103\/0253-7613.302500-27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/hel.12182","article-title":"Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases","author":"Nam","year":"2015","journal-title":"Helicobacter"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:50:37Z","timestamp":1786733437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_364_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"alternative-id":["302500"],"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_364_19","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}